Diagnosis & Disease Information

Bladder Cancer Drug R&D Falls Short

A principal reason for poor outcomes among bladder cancer patients is metastatic disease during follow-up. With currently available drugs, metastatic disease to other solid organs is only curable in less than 10% of patients, according to Virginia urologist Dan Theodorescu, MD, PhD.

Colitis After Cystectomy

A study of patients who experienced Clostridium difficile colitis (CDC) following cystectomy found that the infection did not significantly affect patients’ hospital course.

Urinary Schistosomiasis May Increase

SAN FRANCISCO—Urinary schistosomiasis is a common infection in sub-Saharan Africa and the Mideast, and more cases could surface in the United States because of greater international travel and immigration from those regions, according to an infectious disease specialist.

Antibiotic May Ease Adverse Effects of BCG

Prophylaxis with ofloxacin decreases the incidence of moderate-to-severe adverse effects from bacillus Calmette-Guérin (BCG) intravesical therapy in patients with superficial bladder cancer, French researchers reported. Ofloxacin is a fluoroquinolone with tuberculostatic properties.

Next post in News